ArticleThe Journal of clinical investigation2026

DYRK1A enhances antitumor immunity in type 1 conventional dendritic cells via mTORC1 activation.

Hongjiao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.